We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

227 hedge funds and large institutions have $693M invested in Nektar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 59 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

439% more call options, than puts

Call options by funds: $3.92M | Put options by funds: $727K

34% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 59

0.24% more ownership

Funds ownership: 6.29% → 6.53% (+0.24%)

5% less funds holding

Funds holding: 239 → 227 (-12)

18% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 45

27% less capital invested

Capital invested by funds: $950M → $693M (-$257M)

Holders
227
Holders Change
-12
Holders Change %
-5.02%
% of All Funds
3.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
79
Reduced
59
Closed
45
Calls
$3.92M
Puts
$727K
Net Calls
+$3.19M
Net Calls Change
+$9.71M

Top Buyers

1
BlackRock
BlackRock
New York
+$23M
2
First Trust Advisors
First Trust Advisors
Illinois
+$14.5M
3
GPP
Great Point Partners
Connecticut
+$13.2M
4
State Street
State Street
Massachusetts
+$12.3M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$5.64M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$21.6M
2
BG
Bellevue Group
Switzerland
-$20.1M
3
Millennium Management
Millennium Management
New York
-$10M
4
MC
Maverick Capital
Texas
-$6.62M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
26
Legal & General Group
United Kingdom
$2.36M +$5.99K +95 +0.2%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
27
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$2.28M +$2.52M +39,941 New
State of New Jersey Common Pension Fund D
28
State of New Jersey Common Pension Fund D
New Jersey
$2.23M +$1.46M +23,165 +146%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$2.1M +$469K +7,432 +25%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$2.09M -$381K -6,045 -14%
RPAM
31
Rhenman & Partners Asset Management
Sweden
$2.09M -$269K -4,259 -10%
AQR Capital Management
32
AQR Capital Management
Connecticut
$1.9M +$1.34M +21,162 +174%
Walleye Capital
33
Walleye Capital
New York
$1.85M +$471K +7,468 +30%
Tudor Investment Corp
34
Tudor Investment Corp
Connecticut
$1.84M +$46.7K +740 +2%
Citadel Advisors
35
Citadel Advisors
Florida
$1.82M -$2.23M -35,416 -53%
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.66M – – –
AG
37
Algert Global
California
$1.65M +$1.51M +24,000 +493%
TCM
38
Tang Capital Management
California
$1.63M – – –
Two Sigma Investments
39
Two Sigma Investments
New York
$1.61M -$206K -3,265 -10%
Axa
40
Axa
France
$1.54M +$1.48M +23,526 +683%
Public Sector Pension Investment Board (PSP Investments)
41
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.31M – – –
PAMS
42
Pictet Asset Management (Switzerland)
Switzerland
$1.31M +$1.39M +22,032 +2,400%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.25M – – –
Bank of America
44
Bank of America
North Carolina
$1.23M +$1.09M +17,329 +405%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$1.19M +$309K +4,904 +31%
Assenagon Asset Management
46
Assenagon Asset Management
Luxembourg
$1.14M +$1.2M +19,026 +2,057%
OQS
47
Occudo Quantitative Strategies
Florida
$1.1M +$796K +12,617 +187%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$1.06M +$737K +11,685 +169%
New York State Teachers Retirement System (NYSTRS)
49
New York State Teachers Retirement System (NYSTRS)
New York
$1.03M – – –
Macquarie Group
50
Macquarie Group
Australia
$999K – – –
1
2
3 4 5

NKTR Hedge Fund Activity: Q2 2022 in Review

227 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2022, worth a combined $693M — down 27% from $950M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of NKTR and 37 opened new positions — a net loss of 8 holders — while 59 trimmed existing stakes and 79 added.

The largest buyer was BlackRock, adding an estimated $23M. The largest seller was Camber Capital Management, exiting entirely with an estimated $21.6M sold.

  • 227 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2022, down from 239 in Q1 2022.
  • Funds reported $693M of Nektar Therapeutics stock for Q2 2022, down 27% quarter-over-quarter.
  • 37 funds opened new Nektar Therapeutics positions in Q2 2022 and 45 closed out, a net change of -8 holders.
  • The largest Nektar Therapeutics buyer in Q2 2022 was BlackRock, an estimated $23M added.
  • The largest Nektar Therapeutics seller in Q2 2022 was Camber Capital Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q2 2022.